The CEO's $21.5M sale is the dominant signal, C-suite cluster sells without any buys warrant attention. However, at 0.2% of market cap, this is below the 0.5% threshold for high materiality. Monitor for any upcoming 8-K (earnings, guidance, or M&A) that could explain the timing. The stock's 94% analyst bullishness and strong institutional ownership provide a counterweight.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 11 $125.35entry
- T+1 · 3mo ago −0.41%α −0.67% · $124.83
- T+5 · 3mo ago −2.60%α −2.19% · $122.09
- T+20 · 2mo ago −3.17%α −2.11% · $121.37
- T+60 · 13d ago +12.51%α +13.00% · $141.03
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three top executives at Encompass Health (CEO, CFO, General Counsel) sold a combined ~$3.69M in open-market sales on August 10, 2026. The CEO's sale of $21.5M dominates the cluster, representing ~0.17% of the company's $12.5B market cap, a modest but notable insider sell-off. The cluster is amplified by the CEO's participation and the absence of any buys, though the dollar amount relative to market cap is below the 0.5% threshold for high materiality.
Key Financial Metrics
Key Facts
- CEO Mark J. Tarr sold 173,148 shares for ~$21.7M on Aug 10, 2026
- CFO Douglas E. Coltharp sold 18,869 shares for ~$2.37M on Aug 10, 2026
- General Counsel John Patrick Darby sold 8,906 shares for ~$1.12M on Aug 10, 2026
- Total cluster value: ~$25.2M (0.2% of $12.5B market cap)
- All three sales were open-market transactions, no 10b5-1 plan indicated
- No insider purchases in the cluster window
Financial Impact
Total insider sales of ~$25.2M represent 0.2% of market cap, modest but concentrated among top C-suite
Risk Factors
- CEO selling $21.5M may signal peak valuation or upcoming headwinds
- Cluster sell with no buys suggests uniform bearish view among top executives
- No 10b5-1 plan disclosed, sales appear discretionary
- Recent insider activity (30d) shows $25.2M in total sales with zero buys
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EHC-1786474077319 |
Track record
14 reports on EHC
2 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +8.88% at T+60 after the Aug 5, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 6, 202610d ago 8-K Neutral 4/10 Entry $137.54 to $141.15 Now $142.11 +3.32% ▲ +2.62% +0.26% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 No price data
- Oct 28, 202619d ago Press Release Bullish 6/10 Entry $131.49 to $135.90 Now $142.11 +8.08% ▲ +3.35% +5.13% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $122.09 to $131.49 Now $142.11 +16.40% ▲ +7.70% +8.08% vs SPY
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $124.09 to $124.10 Now $142.11 +14.52% ▲ +0.01% −0.70% vs SPY
- Oct 22, 202625d ago Press Release Neutral 2/10 Entry $126.01 to $124.09 Now $142.11 +12.78% ▼ −1.52% −1.00% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $119.80 to $120.97 Now $142.11 +18.62% ▲ +0.98% +0.30% vs SPY
- Sep 1, 202610w ago Insider Cluster Neutral 3/10 Entry $122.05 to $121.18 Now $142.11 +16.44% ▼ −0.71% −1.16% vs SPY
- Aug 11, 202613w ago Insider Cluster Bearish 5/10 Viewing Entry $125.35 to $124.83 Now $142.11 −13.37% ▲ +0.41% +0.67% vs SPY
- Aug 5, 202614w ago Press Release Bullish 7/10 Entry $124.82 to $125.23 Now $142.11 +13.85% ▲ +0.33% −0.28% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers